1.Effect of Dietary CLA Isomers on Apoptosis and Cell Proliferation in Colonic Mucosa of DMH-Treated Rats.
Hyung Suh PARK ; Pil Su KWON ; Jung Hy PARK ; Yeong Lae HA
The Korean Journal of Nutrition 2003;36(7):661-666
The study was designed to compare the anti-carcinogenic effect of conjugated linoleic acid (CLA) isomers on colon carcinogenesis in 1,2-dimethylhydrazine (DMH)-treated rats by determining the levels of apoptosis, cell proliferation, eicosanoids and 1,2-diacylglycerol (DAG) in colonic mucosa. Sixty male Sprague Dawley rats were randomly divided into 3 groups depending on the types of CLA isomers, i.e. BT group (no CLA contained), CLA-C group (cis-9, trans11 isomer contained), and CLA- T group (trans-10, cis-12 isomer contained). The experimental diet was composed of protein at 20%, carbohydrate at 56.2%, and fat at 14.5% including 0.8% CLA isomers by weight. The experimental diet was fed for 14 weeks with the initiation of intramuscular injection of DMH, which was injected twice a week for 6 weeks to give total dose of l80mg per kg body weight. Two CLA isomers (c9t11 and t10c12) significantly increased the relative percentage of apoptosis but reduced cell proliferation in mucosal cell and also the levels of PGE2, TXB2, and DAG in colonic mucosa. However, there was no significant differences in anti-carcinogenic effect between c9t11 isomer and t10c12 isomer. Overall, colon carcinogenesis could be significantly inhibited by CLA isomers by increasing apoptosis and reducing cell proliferation, the levels of eicosanoids and DAG in colonic mucosa.
1,2-Dimethylhydrazine
;
Animals
;
Anticarcinogenic Agents
;
Apoptosis*
;
Body Weight
;
Carcinogenesis
;
Cell Proliferation*
;
Colon*
;
Colonic Neoplasms
;
Diet
;
Dimenhydrinate
;
Dinoprostone
;
Eicosanoids
;
Humans
;
Injections, Intramuscular
;
Linoleic Acid
;
Male
;
Mucous Membrane*
;
Rats*
;
Rats, Sprague-Dawley
2.Anomalous Systemic Arterial Supply to Normal Basal Segments of Left Lower Lobe: A Report of Two Cases.
Ki Man LEE ; Jong Joon AHN ; In Du JEONG ; Byung Chul KIM ; Je Kyoun SHIN ; Jong Pil JUNG ; Jae Cheol HWANG ; Jae Hee SUH
Tuberculosis and Respiratory Diseases 2001;50(6):710-717
Two cases of an anomalous systemic arterial supply to the basal segments of the left lower lobe without pulmonary wequestration are presented. In the first case, a preoperative diagnosis was made by chest CT, and confirmed by angiograpy, in a 22-year old man who had a recurrent hemoptysis. There was systemic arterial supply that originated from the thoracic descending aorta and no pulmonary arterial supply to the basilar segment of the left lower lobe. However, the pulmonary parenchyma was normal without sequestration. Ligation of the abnormal artery and a left lower lobectomy were performed without complication. In the second case, there were characteristic features of this anomaly on chest CT and the angiogram in a 31-year-old man with symptoms of hemoptysis. The patient refused surgery.
Adult
;
Aorta, Thoracic
;
Arteries
;
Bronchopulmonary Sequestration
;
Diagnosis
;
Hemoptysis
;
Humans
;
Ligation
;
Tomography, X-Ray Computed
3.Results of Screening Colonoscopy in Asymptomatic Average-risk Koreans at a Community-based Secondary Hospital.
Jong Kyu KIM ; Yong Sung CHOI ; Jung Pil SUH ; In Taek LEE ; Eui Gon YOUK ; Doo Seok LEE
Korean Journal of Gastrointestinal Endoscopy 2010;41(5):266-272
BACKGROUND/AIMS: Colonoscopy has emerged as the dominant colorectal cancer screening strategy, yet the data on the results of performing screening colonoscopy in asymptomatic average risk Koreans is limited. The aim of this study is to determine the results of screening colonoscopy at a community-based single center in Korea. METHODS: A total of 13,743 individuals (5,935 males and 7,808 females, age: 50.6+/-11.8 years) who underwent screening colonoscopy at a community based hospital from April 2006 to March 2008 were analyzed. RESULTS: Of the 13,743 subjects, neoplasia, advanced neoplasia and early colon cancer were detected in 3,270 subjects (23.8%), 315 subjects (2.3%) and 60 subjects (0.5%), respectively. The prevalence of neoplasia and advanced neoplasia increased with age (p<0.001), and this was higher among males as compared to that of females (p<0.001). Of the 3,666 subjects with neoplasia, 1,440 subjects (38.3%) had multiple neoplasia. Old age and male gender were associated with multiple neoplasia. CONCLUSIONS: The overall prevalence of colorectal neoplasia in asymptomatic average-risk Koreans at a community based hospital is comparable with that in a health care setting or university hospitals. Old age and male gender are associated with a higher risk of colorectal neoplasia and having multiple neoplasia.
Colonic Neoplasms
;
Colonoscopy
;
Colorectal Neoplasms
;
Delivery of Health Care
;
Female
;
Hospitals, University
;
Humans
;
Korea
;
Male
;
Mass Screening
;
Prevalence
4.Steroid Therapy in Phenytoin Hypersensitivity Syndrome Patient.
Young Ok KIM ; Jung Pil SUH ; Eun Il KIM ; Seok Goo CHO ; Chang Don LEE ; Jong Yuk YI ; Do Sung YOO ; Dal Soo KIM
Journal of Korean Neurosurgical Society 2000;29(12):1673-1676
No abstract available.
Humans
;
Hypersensitivity*
;
Phenytoin*
5.Acute Renal Failure and Ischemic Bowel Disease Complicated by Acute Pyelonephritis in a Patient with Systemic Lupus Erythematosus.
Yoon Suk CHOI ; Young Ok KIM ; Jae Hyung JO ; Jung Sun KIM ; Young Geun HYUN ; Jung Pil SUH ; Jun Ki MIN ; Sun Ae YOON ; Byung Kee BANG
Korean Journal of Nephrology 2000;19(4):740-744
Acute infection increases disease activity in patients with systemic lupus erythematosus(SLE) and causes life threatening complication such as acute renal failure or ischemic bowel disease. We here report a case of acute renal failure and ischemic bowel disease complicated by acute pyelonephritis in a patient with SLE. A 19-year-old woman was admitted for high fever and right flank pain. Urine examination revealed acute pyelonephritis. Thrombocytopenia, proteinuria, positive antinuclear antibody and anti-dsDNA, false positive VDRL confirmed SLE. The pyelonephritis improved with antibiotic treatment, but oliguria and abdominal pain and ascites newly developed. Kidney biopsy and abdominal computed tomography revealed lupus nephritis type IV and ischemic bowel disease, respectively. After methylprednisolone and cyclophosphamide treatment, the patient improved.
Abdominal Pain
;
Acute Kidney Injury*
;
Antibodies, Antinuclear
;
Ascites
;
Biopsy
;
Cyclophosphamide
;
Female
;
Fever
;
Flank Pain
;
Humans
;
Kidney
;
Lupus Erythematosus, Systemic*
;
Lupus Nephritis
;
Methylprednisolone
;
Oliguria
;
Proteinuria
;
Pyelonephritis*
;
Thrombocytopenia
;
Young Adult
6.A case of Pick's disease presenting with progressive nonfluent speech.
Sung Shin AHN ; Duk L NA ; Pil Wook JUNG ; Jung Il LEE ; Yeon Lim SUH ; Sang Eun KIM
Journal of the Korean Neurological Association 1997;15(5):1162-1172
BACKGROUND AND SIGNIFICANCE: Frontotemporal dementia is a behavioral disorder arising from nonAlzheimer's disease atrophy of frontal and anterior temporal lobe. Clinical manifestations include frontal lobe dysfunction. Kluver-Bucy syndrome or progressive language impairments. Two types of histological change underline, the atrophy. The commoner pathology is nerve cell loss and spongiform change with astrocytic gliosis. The second one is typical Pick-type histology characterized by intraneuronal inclusion body and astrocytic gliosis. We report a case with biopsy proved Pick's disease presenting with progressive nonfluent speech. CASE: A 41-years, old right-handed woman developed progressive language impairment over a period of 6 months. Brain MRI revealed asymmetric frontotemporal cortical atrophy more severe on the left side and 18F-FDG-brain, PET showed hypometabolism in the same area. Neuropsychological test including Korean version-Western Aphasia Battery revealed non-fluent speech as well as frontal lobe, dysfunction. A biopsy from left frontal lobe, demonstrate neuronal loss and diffuse astrogliosis. In the cytoplasm of remaining neurons are eosinophilic inclusion bodies which are neurofilament-positive with immunostaining. Senile plaque, neurofibrillary tangle and cortical Lewy body were absent. COMMENT: We report a case presenting with progressive nonfluent speech whose imaging and pathological findings are compatible with Pick's disease, which may be the first biopsy proven case in Korea.
Aphasia
;
Atrophy
;
Biopsy
;
Brain
;
Cytoplasm
;
Eosinophils
;
Female
;
Frontal Lobe
;
Frontotemporal Dementia
;
Gliosis
;
Humans
;
Inclusion Bodies
;
Kluver-Bucy Syndrome
;
Korea
;
Lewy Bodies
;
Magnetic Resonance Imaging
;
Neurofibrillary Tangles
;
Neurons
;
Neuropsychological Tests
;
Pathology
;
Pick Disease of the Brain*
;
Plaque, Amyloid
;
Temporal Lobe
7.A Case of Biliary Cast Syndrome with a Biliary Stricture and Suppurative Cholangitis after Liver Transplantation.
Jung Pil SUH ; In Seok LEE ; Jae Hyuck CHANG ; Jung Hyun KWON ; Won Haing HUR ; Si Hyun BAE ; Myung Gyu CHOI ; In Sik CHUNG ; Dong Goo KIM
Korean Journal of Gastrointestinal Endoscopy 2007;35(4):281-286
Biliary complications after liver transplantation occur in 13~35% of patients. Biliary cast syndrome, cast formation of biliary sludge along the bile duct, can develop in 4~18% of liver transplant recipients, although the incidence rate is significantly decreasing due to the improvement of graft harvesting and preservation. It is very important that early diagnosis and effective management of biliary cast syndrome be performed when there is a bile duct stricture or dilatation associated with jaundice and cholangitis in the recipient after liver transplantation, due to the possibility of retransplantation and death of the patient from graft loss. We report a case of a biliary cast formed with suppurative cholangitis and extracted incidentally with a plastic biliary stent during an endoscopic procedure after cadaveric liver transplantation, in which the ERCP findings revealed a stricture at the anastomosis site of the common bile duct and cholangitis.
Bile
;
Bile Ducts
;
Cadaver
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangitis*
;
Common Bile Duct
;
Constriction, Pathologic*
;
Dilatation
;
Early Diagnosis
;
Humans
;
Incidence
;
Jaundice
;
Liver Transplantation*
;
Liver*
;
Plastics
;
Stents
;
Superior Mesenteric Artery Syndrome*
;
Transplantation
;
Transplants
8.Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience.
Yong Pil CHONG ; Shin KIM ; Ok Bae KO ; Ja Eun KOO ; Danbi LEE ; Sang Hyoung PARK ; Soo Jung PARK ; Daeho LEE ; Sang We KIM ; Cheolwon SUH
Journal of Korean Medical Science 2008;23(5):819-824
Immunoglobulin (Ig) D multiple myeloma (MM) accounts for 2% of all MM cases and has been reported to be associated with poor prognosis compared with other MM subtypes. The aim of the present study was to compare the effects of high-dose melphalan treatment and autologous stem cell transplantation (ASCT) on the survival of patients with IgD MM and patients with other MM subtypes. Between November 1998 and January 2005, a total of 77 patients with MM who underwent ASCT at the Asan Medical Center were enrolled in this study. High-dose melphalan (total 200 mg/m2) was used as high-dose chemotherapy. The study population was divided into two groups based on MM subtype: those with IgD MM; and those with other MM subtypes. A total of 8 patients with IgD MM were identified, accounting for about 10% of the study population. Thirty-six patients (47%) had IgG MM, 17 patients (22%) had IgA MM, and 16 patients (20%) had free light-chain MM. The two groups were similar in baseline characteristics. The median follow-up was 17 months and the median overall survival (OS) was 39 months. In the IgD MM group, median eventfree survival (EFS) and OS were 6.9 and 12 months, respectively. In the patients with other MM subtypes, median EFS and OS were 11.5 and 55.5 months (p=0.01, p<0.01), respectively. Multivariate analysis of all patients identified IgD subtype (p=0.002) and Southwest Oncology Group (SWOG) stage 2 or greater at the time of ASCT (p=0.01) as adverse prognostic factors for survival. In this small study at a single center in Korea, patients with IgD MM had poorer outcomes after ASCT than did patients with other MM subtypes.
Adult
;
Aged
;
Female
;
Humans
;
Immunoglobulin D/*chemistry
;
Male
;
Melphalan/*pharmacology
;
Middle Aged
;
Multiple Myeloma/*drug therapy/genetics/*immunology
;
Myeloablative Agonists/*pharmacology
;
Prognosis
;
Retrospective Studies
;
Stem Cell Transplantation/*methods
;
Transplantation, Autologous
;
Treatment Outcome
9.Evaluation of changes in random blood glucose and body mass index during and after completion of chemotherapy in children with acute lymphoblastic leukemia.
Kyong Won BANG ; Soo Young SEO ; Jae Wook LEE ; Pil Sang JANG ; Min Ho JUNG ; Nack Gyun CHUNG ; Bin CHO ; Dae Chul JEONG ; Byung Kyu SUH ; Hack Ki KIM
Korean Journal of Pediatrics 2012;55(4):121-127
PURPOSE: Improved survival of patients with childhood acute lymphoblastic leukemia (ALL) has drawn attention to the potential for late consequences of previous treatments among survivors, including metabolic syndrome. In this study, we evaluated changes in 3 parameters, namely, random blood glucose, body mass index (BMI), and Z score for BMI (Z-BMI), in children with ALL during chemotherapy and after completion of treatment. METHODS: Patients newly diagnosed with ALL from January, 2005 to December, 2008 at Saint Mary's Hospital, The Catholic University of Korea, who completed treatment with chemotherapy only were included (n=107). Random glucose, BMI, and Z-BMI were recorded at 5 intervals: at diagnosis, before maintenance treatment, at completion of maintenance treatment, and 6 and 12 months after completion of maintenance treatment. Similar analyses were conducted on 2 subcohorts based on ALL risk groups. RESULTS: For random glucose, a paired comparison showed significantly lower levels at 12 months post-treatment compared to those at initial diagnosis (P<0.001) and before maintenance (P<0.001). The Z-BMI score was significantly higher before maintenance than at diagnosis (P<0.001), but decreased significantly at the end of treatment (P<0.001) and remained low at 6 months (P<0.001) and 12 months (P<0.001) post-treatment. Similar results were obtained upon analysis of risk group-based subcohorts. CONCLUSION: For a cohort of ALL patients treated without allogeneic transplantation or cranial irradiation, decrease in random glucose and Z-BMI after completion of chemotherapy does not indicate future glucose intolerance or obesity.
Blood Glucose
;
Body Mass Index
;
Child
;
Cohort Studies
;
Cranial Irradiation
;
Glucose
;
Glucose Intolerance
;
Humans
;
Korea
;
Matched-Pair Analysis
;
Obesity
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Saints
;
Survivors
;
Transplantation, Homologous
10.Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor in Multiple Myeloma.
Jae Pil YUN ; Cheolwon SUH ; Eunkyoung LEE ; Jai Won CHANG ; Won Seok YANG ; Jung Sik PARK ; Su Kil PARK
Journal of Korean Medical Science 2006;21(4):639-644
A new staging system for multiple myeloma (MM) has utilized serum concentrations of beta 2-microglobulin (S beta2 M) and albumin as important prognostic factors for survival. Since S beta2 M is an indicator of glomerular filtration rate, we compared the prognostic values of S beta2 M and 24-hr urinary creatinine clearance (Ccr) in patients with MM. We retrospectively reviewed the records of 170 MM patients from January 1996 to November 2003 whose 24-hr urinary Ccr was available at the time of diagnosis. We found that pretreatment S beta2 M was inversely related to Ccr (Spearman's correlation coefficient=-0.787). In univariate analysis, the hazard ratio (HR) of death was 1.043 (p<0.001) for S beta2 M and 0.985 (p<0.001) for Ccr. Multivariate analysis showed that S beta2 M (HR 1.030, p=0.010) and Ccr (HR 0.993, p=0.059) were significant prognostic factors in patients' survival. In conclusion, 24-hr urinary Ccr may be utilized for staging of patients with MM.
beta 2-Microglobulin/*blood
;
Survival Analysis
;
Retrospective Studies
;
Prognosis
;
Neoplasm Staging/methods
;
Multivariate Analysis
;
Multiple Myeloma/drug therapy/metabolism/*pathology
;
Creatinine/*urine